We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Goes After Dietary Supplements With Undeclared Ingredients
FDA Goes After Dietary Supplements With Undeclared Ingredients
August 1, 2008
U.S. marshals acting for the FDA seized two lots of Miami-based SEI Pharmaceuticals’ Xiadafil VIP tablets that the company refused to recall at the request of the agency.